ClariVest Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-77,054	Closed	-$1.89M	–	850
2023 Q2	$1.89M	Sell	77,054 -11,678	-13%	-$293K	0.09%	138
2023 Q1	$2.06M	Buy	88,732 +52	+0.1%	+$1.33K	0.09%	170
2022 Q4	$2.25M	Sell	88,680 -241	-0.3%	-$5.91K	0.11%	149
2022 Q3	$1.72M	Sell	88,921 -17,296	-16%	-$440K	0.08%	179
2022 Q2	$2.71M	Sell	106,217 -37,500	-26%	-$875K	0.12%	149
2022 Q1	$3.7M	Buy	143,717 +46,574	+48%	+$1.38M	0.15%	148
2021 Q4	$4.07M	Buy	+97,143	New	+$3.81M	0.13%	156
2021 Q3	–	Sell	-8,896	Closed	-$420K	–	831
2021 Q2	$420K	Buy	8,896 +3	+0%	+$136	0.01%	447
2021 Q1	$456K	Sell	8,893 -2,768	-24%	-$149K	0.02%	425
2020 Q4	$311K	Sell	11,661 -16,033	-58%	-$521K	0.01%	459
2020 Q3	$951K	Buy	+27,694	New	+$1.19M	0.03%	307